Americans Showing Hesitancy Toward COVID-19 Testing

WEDNESDAY, Dec. 16, 2020 -- Three in four Americans who believed they needed a COVID-19 test report that they either did not get one or delayed getting one, according to the results of a survey released by Quest Diagnostics.

An online survey of 2,050 U.S. adults was conducted by The Harris Poll on behalf of Quest Diagnostics between Nov. 10 and 12, 2020.

According to the results of the survey, reasons cited for avoiding or delaying a COVID-19 test included concerns about exposure to the virus (30 percent), thinking it was very unlikely they had COVID-19 (21 percent), concerns over having to quarantine while waiting for results or if they were positive (15 percent), and cost (15 percent). Avoiding or delaying testing was more common among Hispanic/Latinx adults (83 percent) versus Whites (non-Hispanic; 72 percent) and Blacks (72 percent). The results of the survey also confirmed previous findings that the majority of U.S. adults (60 percent) have skipped or delayed in-person medical treatments or appointments during the COVID-19 pandemic.

"With a vaccine likely not making its way to the general public until spring at the earliest, the health care community needs to do a better job of helping Americans get back to routine care now," Harvey W. Kaufman, M.D., head of the Health Trends Research Program for Quest Diagnostics, said in a statement. "Early diagnosis can save lives and putting off preventative care and chronic disease treatment could make the difference between life and death."

More Information

© 2020 HealthDay. All rights reserved.

Posted: December 2020

Further Support and Information on COVID-19

Read this next

Hyperglycemia, Hypoglycemia Linked to Poor Outcomes in COVID-19

WEDNESDAY, Dec. 16, 2020 -- For patients with COVID-19, hyperglycemia and hypoglycemia are associated with poor outcomes, according to a study published online Dec. 15 in Diabetes...

One in Five Patients Hospitalized With COVID-19 Dies

WEDNESDAY, Dec. 16, 2020 -- Severe acute complications are common among adults hospitalized with COVID-19, leading to an inpatient mortality rate of 20 percent, according to a...

FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19

TUESDAY, Dec. 15, 2020 -- The first nonprescription COVID-19 test that enables people to collect samples and get results at home has received emergency use authorization from the...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.